Xxera/openscience/retractions

Record #44124

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma

Wenlong Feng, Dylan C Dean, Francis J Hornicek, Dimitrios Spentzos, Robert M Hoffman, Huirong Shi, Zhenfeng Duan

Journal

Therapeutic Advances in Medical Oncology

Publisher

SAGE Publications

Original paper date

May 10, 2020

Original DOI

10.1177/1758835920922055

Country

🇨🇳 China · 🇺🇸 United States

Institution

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China · Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA · Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA · AntiCancer Inc., San Diego, CA, USA Department of Surgery, University of California, San Diego, CA, USA

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular

Notes from Retraction Watch

see also: https://pubpeer.com/publications/FA9CABAB1D751591D2E28FFF13DAB0

Citation lifecycle

How this paper is being cited

Pre-retraction

31

Same day

0

Post-retraction

13

% post-retraction

29.5%

~10.5 citations/yr before retraction · ~3.8 citations/yr after

— citing papers

Who is still citing this work

Loading…